Hanson & Doremus Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-65
Closed -$3K – 518
2025
Q3
$3K Buy
+65
New +$3.14K ﹤0.01% 485
2024
Q3
– Sell
-125
Closed -$6K – 449
2024
Q2
$6K Hold
125
– – ﹤0.01% 436
2024
Q1
$6K Buy
+125
New +$6.1K ﹤0.01% 435
2022
Q4
– Sell
-54
Closed -$2K – 560
2022
Q3
$2K Sell
54
-175
-76% -$7.8K ﹤0.01% 505
2022
Q2
$11K Sell
229
-125
-35% -$6.63K ﹤0.01% 439
2022
Q1
$18K Buy
+354
New +$18.3K ﹤0.01% 412
2021
Q4
– Sell
-426
Closed -$21K – 501
2021
Q3
$21K Buy
426
+144
+51% +$7.32K ﹤0.01% 361
2021
Q2
$14K Hold
282
– – ﹤0.01% 350
2021
Q1
$14K Hold
282
– – ﹤0.01% 387
2020
Q4
$14K Hold
282
– – ﹤0.01% 377
2020
Q3
$14K Buy
282
+72
+34% +$3.71K ﹤0.01% 350
2020
Q2
$11K Buy
+210
New +$10.2K ﹤0.01% 378

Other funds holding SNY

Hanson & Doremus Investment Management's SNY Position: Q4 2025 in Review

Hanson & Doremus Investment Management sold out of Sanofi (SNY) in Q4 2025, closing a stake of 65 shares — an estimated $3K sold.

Hanson & Doremus Investment Management first reported a position in SNY in Q2 2020 and held it in 12 quarters. The position peaked at $21K in Q3 2021. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Hanson & Doremus Investment Management reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 65 Sanofi shares in Q4 2025, an estimated $3K.
  • Hanson & Doremus Investment Management first reported a position in Sanofi in Q2 2020 and held it in 12 quarters.
  • Hanson & Doremus Investment Management's Sanofi position peaked at $21K in Q3 2021.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2025, filed 20 Jan 2026.